Lymphotactin: a Cytokine that Represents a New Class of Chemokine

Gregory S. Kelner(Merck Biopharma Co., Ltd. (Japan)), Jacqueline Kennedy(Merck Biopharma Co., Ltd. (Japan)), Kevin B. Bacon(Merck Biopharma Co., Ltd. (Japan)), Sarah Kleyensteuber(Merck Biopharma Co., Ltd. (Japan)), David A. Largaespada(BioScience Laboratories (United States)), Nancy A. Jenkins(BioScience Laboratories (United States)), Neal G. Copeland(BioScience Laboratories (United States)), J. Fernando Bazán(Merck Biopharma Co., Ltd. (Japan)), Kevin W. Moore(Merck Biopharma Co., Ltd. (Japan)), Thomas J. Schall(Merck Biopharma Co., Ltd. (Japan)), Albert Zlotnik(Merck Biopharma Co., Ltd. (Japan))
Science
November 25, 1994
Cited by 662

Abstract

In this study, the cytokine-producing profile of progenitor T cells (pro-T cells) was determined. During screening of a complementary DNA library generated from activated mouse pro-T cells, a cytokine designated lymphotactin was discovered. Lymphotactin is similar to members of both the Cys-Cys and Cys-X-Cys chemokine families but lacks two of the four cysteine residues that are characteristic of the chemokines. Lymphotactin is also expressed in activated CD8+ T cells and CD4-CD8- T cell receptor alpha beta + thymocytes. It has chemotactic activity for lymphocytes but not for monocytes or neutrophils. The gene encoding lymphotactin maps to chromosome one. Taken together, these observations suggest that lymphotactin represents a novel addition to the chemokine superfamily.


Related Papers

No related papers found

Powered by citation graph analysis